CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) was the recipient of a significant growth in short interest in November. As of November 30th, there was short interest totalling 14,800 shares, a growth of 37.0% from the November 15th total of 10,800 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 148.0 days.

CanSino Biologics Stock Performance

CASBF remained flat at C$4.35 during trading on Friday. CanSino Biologics has a 52 week low of C$1.86 and a 52 week high of C$4.35. The firm has a fifty day simple moving average of C$3.77 and a 200-day simple moving average of C$2.93.

About CanSino Biologics

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.